
eCF506
CAS No. 1914078-41-3
eCF506( —— )
Catalog No. M21978 CAS No. 1914078-41-3
eCF506 is a potent and selective inhibitor of SRC (IC50 < 0.5 nM)eCF506, the first small molecule with subnanomolar IC50 for SRC that requires 3 orders of magnitude greater concentration to inhibit ABL.?
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 51 | In Stock |
![]() ![]() |
5MG | 77 | In Stock |
![]() ![]() |
10MG | 113 | In Stock |
![]() ![]() |
25MG | 186 | In Stock |
![]() ![]() |
50MG | 332 | In Stock |
![]() ![]() |
100MG | 478 | In Stock |
![]() ![]() |
200MG | Get Quote | In Stock |
![]() ![]() |
500MG | Get Quote | In Stock |
![]() ![]() |
1G | Get Quote | In Stock |
![]() ![]() |
Biological Information
-
Product NameeCF506
-
NoteResearch use only, not for human use.
-
Brief DescriptioneCF506 is a potent and selective inhibitor of SRC (IC50 < 0.5 nM)eCF506, the first small molecule with subnanomolar IC50 for SRC that requires 3 orders of magnitude greater concentration to inhibit ABL.?
-
DescriptioneCF506 is a potent and selective inhibitor of SRC (IC50 < 0.5 nM)eCF506, the first small molecule with subnanomolar IC50 for SRC that requires 3 orders of magnitude greater concentration to inhibit ABL.?eCF506 exhibits excellent water solubility, an optimal DMPK profile and oral bioavailability, halts SRC-associated neuromast migration in zebrafish embryos without inducing life-threatening heart defects, and inhibits SRC phosphorylation in tumor xenografts in mice.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayTyrosine Kinase
-
TargetSrc
-
RecptorSrc
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1914078-41-3
-
Formula Weight510.63
-
Molecular FormulaC26H38N8O3
-
Purity>98% (HPLC)
-
SolubilityDMSO:62.5 mg/mL (122.40 mM; Need ultrasonic)
-
SMILESCOc1cc(ccc1NC(=O)OC(C)(C)C)-c1nn(CCN2CCC(CC2)N(C)C)c2ncnc(N)c12
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Fraser C, et al. Rapid Discovery and Structure-Activity Relationships of Pyrazolopyrimidines That Potently Suppress Breast Cancer Cell Growth via SRC Kinase Inhibition with Exceptional Selectivity over ABL Kinase. J Med Chem. 2016 May 26;59(10):4697-710.
molnova catalog



related products
-
A-770041
A-770041 is selective and orally active Src-family Lck inhibitor, and the other Src family kinase involved in T-cell signaling.
-
Lyn peptide inhibito...
Cell-permeable inhibitor of Lyn-dependent effects of the IL-5 receptor. Blocks binding of Lyn tyrosine kinase to βc subunit of IL-3/GM-CSF/IL-5 receptors, blocking Lyn activation. Inhibits IL-5 receptor-mediated eosinophil differentiation and survival in vitro. Inhibits airway eosinophilic inflammation in mouse model of asthma.
-
Tirbanibulin Mesylat...
Tirbanibulin Mesylate is an inhibitor of Src that targets the peptide substrate site of Src.